Literature DB >> 8285634

Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.

S Kar1, K Kar, P K Bhattacharya, D K Ghosh.   

Abstract

We previously reported the effectiveness of trans-aconitic acid (TAA) as an antileishmanial compound. Inhibitory effects of TAA along with other antileishmanial compounds on transformation and in vitro multiplication in macrophage cultures of Leishmania donovani have been assessed. The efficacy of TAA in combined chemotherapy of experimental visceral leishmaniasis has also been evaluated along with those of commonly used antileishmanial compounds such as sodium stibogluconate, pentamidine, and allopurinol. TAA (2 mM) inhibited transformation of L. donovani amastigotes to promastigotes by 95.2%, whereas in combination with pentamidine (5 micrograms/ml), allopurinol (10 micrograms/ml), and sodium stibogluconate (50 micrograms of Sb per ml), it inhibited transformation by about 100, 99, and 98.5%, respectively. Sodium stibogluconate (20 micrograms of Sb per ml), pentamidine (2 micrograms/ml), and allopurinol (5 micrograms/ml) suppressed the amastigote burden in peritoneal macrophage cultures from BALB/c mice by 32.6, 56.1, and 46.3%, respectively. When these three drugs were used along with TAA (5 mM), the parasite loads were reduced by 100, 100, and 88.1%, respectively. TAA (5 mM) alone suppressed the amastigote burden by 59.5%. In experimental visceral leishmaniasis in hamsters (1-month model), TAA at a dose of 200 mg/kg of body weight per day suppressed the spleen parasite load by 73.5%, and TAA in combination with sodium stibogluconate (50 mg of Sb per kg per day), pentamidine (8 mg/kg/day), and allopurinol (15 mg/kg/day) inhibited the spleen parasite load by 98, 98.9, and 97%, respectively. Individually, these three drugs inhibited the parasite load by 35, 20, and 22%, respectively. TAA (400 mg/kg/day) inhibited the spleen parasite load by 99.8%, but an inhibitory effect of approximately 100% was noted when TAA was supplemented with an antileishmanial drug. TAA was administered in experimental animals through oral, intraperitoneal, and intramuscular routes; the intramuscular route was most effective.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8285634      PMCID: PMC192409          DOI: 10.1128/AAC.37.11.2459

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Respiration of Leishmania mexicana amastigotes and promastigotes.

Authors:  D T Hart; K Vickerman; G H Coombs
Journal:  Mol Biochem Parasitol       Date:  1981-11       Impact factor: 1.759

2.  Leishmania mexicana: energy metabolism of amastigotes and promastigotes.

Authors:  D T Hart; G H Coombs
Journal:  Exp Parasitol       Date:  1982-12       Impact factor: 2.011

3.  Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.

Authors:  P A Kager; P H Rees; F M Manguyu; K M Bhatt; B T Wellde; W T Hockmeyer; W H Lyerly
Journal:  Trop Geogr Med       Date:  1984-03

4.  Enzymes of carbohydrate metabolism in Leishmania donovani amastigotes.

Authors:  J C Meade; T A Glaser; P F Bonventre; A J Mukkada
Journal:  J Protozool       Date:  1984-02

5.  Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India.

Authors:  T K Jha
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

6.  Evaluation of allopurinol in the treatment of kala-azar occurring in North Bihar, India.

Authors:  T K Jha
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

7.  Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biological effects and metabolism.

Authors:  J J Marr; R L Berens; D J Nelson; T A Krenitsky; T Spector; S W LaFon; G B Elion
Journal:  Biochem Pharmacol       Date:  1982-01-15       Impact factor: 5.858

8.  Allopurinol in the treatment of visceral leishmaniasis.

Authors:  P A Kager; P H Rees; B T Wellde; W T Hockmeyer; W H Lyerly
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

9.  Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).

Authors:  J D Chulay; H C Spencer; M Mugambi
Journal:  Am J Trop Med Hyg       Date:  1985-07       Impact factor: 2.345

10.  Leishmania donovani: amastigote inhibition and mode of action of berberine.

Authors:  A K Ghosh; F K Bhattacharyya; D K Ghosh
Journal:  Exp Parasitol       Date:  1985-12       Impact factor: 2.011

View more
  3 in total

1.  Genetic and Biochemical Characterization of a Gene Operon for trans-Aconitic Acid, a Novel Nematicide from Bacillus thuringiensis.

Authors:  Cuiying Du; Shiyun Cao; Xiangyu Shi; Xiangtao Nie; Jinshui Zheng; Yun Deng; Lifang Ruan; Donghai Peng; Ming Sun
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

Review 2.  Leishmaniasis treatment--a challenge that remains: a review.

Authors:  Dilvani O Santos; Carlos E R Coutinho; Maria F Madeira; Carolina G Bottino; Rodrigo T Vieira; Samara B Nascimento; Alice Bernardino; Saulo C Bourguignon; Suzana Corte-Real; Rosa T Pinho; Carlos Rangel Rodrigues; Helena C Castro
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

Review 3.  Aconitic Acid Recovery from Renewable Feedstock and Review of Chemical and Biological Applications.

Authors:  Gillian O Bruni; K Thomas Klasson
Journal:  Foods       Date:  2022-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.